Timolol

規格

26839-75-8CAS番号

248-032-6EC番号

(2S)-1-(tert-butylamino)-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propan-2-olIUPAC名

C13H24N4O3S化学式

316.42 g/mol分子量

timolol; 26839-75-8; Betimol; Timololum; Timolol anhydrous; (-)-3-Morpholino-4-(3-tert-butylamino-2-hydroxypropoxy)-1,2,5-thiadiazole; S-(-)-3-(3-tert-Butylamino-2-hydroxypropoxy)-4-morpholino-1,2,5-thiadiazole; (S)-1-(1,1-(Dimethylethyl)amino)-3-((4-(4-morpholinyl)-1,2,5-thiadiazol-3-yl)oxy)-2-propanol; 5JKY92S7BR; (S)-1-(tert-Butylamino)-3-((4-morpholino-1,2,5-thiadiazol-3-yl)oxy)propan-2-ol; CHEBI:9599; Betim; CHEBI:60787; 817W3C6175; CHEBI:39465; Timololo; Nyogel; Tiopex; Glau-opt; 2-Propanol, 1-((1,1-dimethylethyl)amino)-3-((4-(4-morpholinyl)-1,2,5-thiadiazol-3-yl)oxy)-, hemihydrate, (S)-; RefChem:898126; C07AA06; S01ED01; 1-(tert-butylamino)-3-((4-morpholino-1,2,5-thiadiazol-3-yl)oxy)propan-2-ol; MK950; L714,465; L 714,465; 248-032-6; (S)-timolol; (2S)-1-(tert-butylamino)-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol; Timololum [INN-Latin]; Timolol (INN); DTXSID4023674; Betimol (TN); Timopic; (S)-timolol (anhydrous); CHEMBL499; (2S)-1-(tert-butylamino)-3-{[4-(morpholin-4-yl)-1,2,5-thiadiazol-3-yl]oxy}propan-2-ol; (2S)-1-((1,1-dimethylethyl)amino)-3-((4-(4-morpholinyl)-1,2,5-thiadiazol-3-yl)oxy)-2-propanol; NCGC00016798-06; TIMOLOL [INN]; 2-Propanol, 1-((1,1-dimethylethyl)amino)-3-((4-(4-morpholinyl)-1,2,5-thiadiazol-3-yl)oxy)-, (2S)-; DTXCID203674; (2S)-3-[(tert-butyl)amino]-1-(4-morpholin-4-yl(1,2,5-thiadiazol-3-yl)oxy)propa n-2-ol; 2-Propanol, 1-[(1,1-dimethylethyl)amino]-3-[[4-(4-morpholinyl)-1,2,5-thiadiazol-3-yl]oxy]-, (2S)-; CAS-26839-75-8; HSDB 6533; Timolol [USAN:INN]; EINECS 248-032-6; CAS-26921-17-5; UNII-5JKY92S7BR; (S)-Timolol; Arutimol; L-Timolol; Tocris-0649; TIMOLOL [HSDB]; TIMOLOL [MI]; Prestwick0_000948; Prestwick1_000948; Prestwick2_000948; Prestwick3_000948; Lopac-T-6394; TIMOLOL [WHO-DD]; SCHEMBL4912; Lopac0_001189; Oprea1_640981; BSPBio_000916; GTPL565; BIDD:GT0073; SPBio_003075; BPBio1_001008; HMS2089I11; HMS3259C20; Tox21_110614; BDBM50292219; EBC-26768; AKOS015969764; Tox21_110614_1; DB00373; NC00592; NCGC00016038-01; NCGC00016038-02; NCGC00016798-01; NCGC00016798-02; NCGC00016798-03; NCGC00016798-05; NCGC00016798-07; NCGC00016798-08; NCGC00016798-09; NCGC00016798-11; NCGC00016798-20; NCGC00022033-02; NCGC00022033-04; NCGC00022033-05; (2S)-1-[(1,1-dimethylethyl)amino]-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol; 2-Propanol, 1-((1,1-dimethylethyl)amino)-3-((4-(4-morpholinyl)-1,2,5-thiadiazol-3-yl)oxy)-, (S)-; DA-78480; HY-17494; ST072193; AB00513729; CS-0009238; NS00115928; C07141; D08600; AB00513729-17; EN300-17982937; Q413994; BRD-K08806317-050-03-6; BRD-K08806317-050-29-1; BRD-K08806317-051-01-8; BRD-K08806317-103-02-5; (S)-1-(TERT-BUTYLAMINO)-3-((4-MORPHOLINO-1,2,5-THIADIAZOL-3-YL)OXY)-2-PROPANOL; (S)-1-(tert-butylamino)-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol; (S)-1-tert-Butylamino-3-(4-morpholin-4-yl-[1,2,5]thiadiazol-3-yloxy)-propan-2-ol; (S)-Timolol; (2S)-1-[(1,1-Dimethylethyl)amino]-3-[[4-(4-morpholinyl)-1,2,5-thiadiazol-3-yl]oxy]-2-propanol; 2-Propanol, 1-(tert-butylamino)-3-[(4-morpholino-1,2,5-thiadiazol-3-yl)oxy]-, (S)-(-)- (8CI); 2-Propanol, 1-[(1,1-dimethylethyl)amino]-3-[[4-(4-mor; 1-(tert-butylamino)-3-[4-(1,4-oxazinan-4-yl)-1,2,5-thiadiazol-3-yloxy]-(2S)-propan-2-ol別名